Home/Filings/4/0001209191-17-009824
4//SEC Filing

BioAmber Inc. 4

Accession 0001209191-17-009824

CIK 0001534287operating

Filed

Feb 12, 7:00 PM ET

Accepted

Feb 13, 7:34 AM ET

Size

7.8 KB

Accession

0001209191-17-009824

Insider Transaction Report

Form 4
Period: 2017-02-09
Hartmann Michael A.
Executive Vice President
Transactions
  • Award

    Stock-Option (right to buy)

    2017-02-09+38,55838,558 total
    Exercise: $3.55Exp: 2022-02-08Common Shares (38,558 underlying)
  • Award

    Stock-Option (right to buy)

    2017-02-09+40,00040,000 total
    Exercise: $3.55Exp: 2027-02-08Common Shares (40,000 underlying)
Footnotes (2)
  • [F1]Vesting monthly over one (1) year from the grant date
  • [F2]Vesting as follows: twenty-five percent (25%) vesting at the first anniversary date following the grant date, and the remaining seventy-five percent (75%) vesting on a monthly basis over the three (3) following years.

Issuer

BioAmber Inc.

CIK 0001534287

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001534287

Filing Metadata

Form type
4
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 7:34 AM ET
Size
7.8 KB